AMETEK (NYSE: AME) executive awarded new stock options and shares

Rhea-AI Filing Summary

AMETEK executive Thomas C. Marecic, President – Electronic Instruments, received new equity awards in the form of stock options and restricted shares. He was granted stock options on 3,930 shares of common stock at an exercise price of $212.77 per share, expiring in 2036, which will become exercisable in three equal annual installments beginning on March 18, 2027. He also acquired 1,240 shares of common stock as a restricted stock award issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. To cover taxes on the equity compensation, 253 shares of common stock were withheld, which is treated as a disposition but not an open-market sale. Following these transactions, Marecic directly owns 45,533 shares of common stock, along with additional holdings through a 401(k) plan and shares held by his wife.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Marecic Thomas C

(Last) (First) (Middle)

1100 CASSATT ROAD

(Street)

BERWYN PENNSYLVANIA 19312

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMETEK INC/ [ AME ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRES. - ELECTRONIC INSTRUMENTS

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		A(1)		1,240	A	$212.77	45,786	D
Common Stock	03/18/2026		F(2)		253	D	$212.77	45,533	D
401k Plan								3,048	I	401k Plan
Common Stock/ Serp								13,644	D
Common Stock								348	I	By Wife

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$212.77	03/18/2026		A		3,930		03/18/2027(3)	03/18/2036	Common Stock	3,930	$0	3,930	D

Explanation of Responses:

1. Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.

2. Represents withholding of shares to pay taxes.

3. The stock options will become exercisable in three equal annual installments beginning on March 18, 2027.

Remarks:

	/s/ Lynn Carino, attorney-in-fact for Mr. Marecic	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did AMETEK (AME) executive Thomas C. Marecic receive?

Thomas C. Marecic received stock options and restricted stock. He was granted options on 3,930 shares at an exercise price of $212.77, plus 1,240 shares of restricted common stock under AMETEK’s 2020 Omnibus Incentive Compensation Plan.

How do the new AMETEK (AME) stock options for Thomas C. Marecic vest?

The new stock options vest in three equal annual installments. They become exercisable beginning on March 18, 2027, with the remaining portions vesting annually thereafter, and the options are scheduled to expire in 2036 if not exercised.

Did Thomas C. Marecic sell AMETEK (AME) shares in this Form 4 filing?

No open-market sale is reported; shares were withheld for taxes. The filing shows 253 shares of common stock were withheld to pay tax liabilities related to his equity awards, which is recorded as a disposition but not a market sale.

How many AMETEK (AME) shares does Thomas C. Marecic hold after these transactions?

Marecic holds 45,533 AMETEK common shares directly after the filing. He also has additional indirect and plan-related holdings, including shares in a 401(k) plan and shares held by his wife, plus SERP-related common stock units.

What is the exercise price and expiration for Thomas C. Marecic’s new AMETEK options?

The new options have a $212.77 exercise price and expire in 2036. They cover 3,930 shares of AMETEK common stock and begin vesting on March 18, 2027, in three equal annual installments according to the grant terms.